Docetaxel with or without Ramucirumab after Platinum-Based Chemotherapy and Checkpoint Inhibitors in Advanced Urothelial Carcinoma: A Pre-Specified Subgroup Analysis from the Phase 3 RANGE Trial

  1. Drakaki, A.
  2. Kirby, C.J.
  3. Van Der Heijden, M.S.
  4. Petrylak, D.P.
  5. Powles, T.
  6. Chi, K.N.
  7. Fléchon, A.
  8. Necchi, A.
  9. Géczi, L.
  10. Lee, J.-L.
  11. Gakis, G.
  12. Bracarda, S.
  13. Chowdhury, S.
  14. Lin, C.-C.
  15. Keizman, D.
  16. Vaishampayan, U.N.
  17. Zimmermann, A.H.
  18. Bell-Mcguinn, K.
  19. Castellano, D.
Revista:
Bladder Cancer

ISSN: 2352-3735,  2352-3727

Ano de publicación: 2020

Volume: 6

Número: 1

Páxinas: 43-52

Tipo: Artigo

DOI: 10.3233/BLC-190252 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus